ATE314839T1 - Prozess zur herstellung einer oralen arzneiform - Google Patents

Prozess zur herstellung einer oralen arzneiform

Info

Publication number
ATE314839T1
ATE314839T1 AT01993458T AT01993458T ATE314839T1 AT E314839 T1 ATE314839 T1 AT E314839T1 AT 01993458 T AT01993458 T AT 01993458T AT 01993458 T AT01993458 T AT 01993458T AT E314839 T1 ATE314839 T1 AT E314839T1
Authority
AT
Austria
Prior art keywords
core
producing
oral medicinal
medicinal form
outer coating
Prior art date
Application number
AT01993458T
Other languages
English (en)
Inventor
Luigi Martini
Philip Smith
Chi Leung Li
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE314839T1 publication Critical patent/ATE314839T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23B—TURNING; BORING
    • B23B37/00—Boring by making use of vibrations of ultrasonic frequency

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT01993458T 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform ATE314839T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0027471.2A GB0027471D0 (en) 2000-11-08 2000-11-08 Processes

Publications (1)

Publication Number Publication Date
ATE314839T1 true ATE314839T1 (de) 2006-02-15

Family

ID=9902924

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01993458T ATE314839T1 (de) 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform
AT05077703T ATE428407T1 (de) 2000-11-08 2001-11-02 Oralen arzneiform mit oeffnungen in der äusseren hülle

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05077703T ATE428407T1 (de) 2000-11-08 2001-11-02 Oralen arzneiform mit oeffnungen in der äusseren hülle

Country Status (9)

Country Link
US (2) US7923027B2 (de)
EP (2) EP1333813B1 (de)
JP (1) JP4290981B2 (de)
AT (2) ATE314839T1 (de)
AU (1) AU2002218280A1 (de)
DE (2) DE60138428D1 (de)
ES (2) ES2256329T3 (de)
GB (1) GB0027471D0 (de)
WO (1) WO2002038131A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
NZ532096A (en) * 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100995486B1 (ko) * 2002-09-28 2010-11-22 맥네일-피피씨, 인코포레이티드 개구가 있는 쉘을 포함하는 속방성 투여형
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
EP1686967A4 (de) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Carvedilol-freie base, salze, wasserfreie formen oder solvate davon, entsprechende pharmazeutische zusammensetzungen, formulierungen mit kontrollierter freisetzung und behandlungs- oder abgabeverfahren
US8067029B2 (en) * 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7404708B2 (en) * 2004-12-07 2008-07-29 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
BRPI0520830A2 (pt) * 2005-12-30 2009-05-19 Accu Break Technologies Inc forma de dosagem farmacêutica sólida, método de subdividir uma forma de dosagem farmacêutica sólida, método de administração de uma parte de uma subunidade ativa de uma forma de dosagem farmacêutica sólida, método de administração de um ingrediente farmacêutico ativo que está presente dentro de uma subunidade ativa de uma forma de dosagem farmacêutica sólida e método de produção de uma forma de dosagem farmacêutica sólida
US8273105B2 (en) 2008-02-20 2012-09-25 Tyco Healthcare Group Lp Compound barb medical device and method
BRPI0822655A2 (pt) * 2008-06-04 2015-06-30 Colgate Palmolive Co Implemento e sistema para cuidado oral
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
AU2009270768A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
CN113840595A (zh) 2019-05-17 2021-12-24 葛兰素史密斯克莱知识产权发展有限公司 基质组合物，其包含(S)-5-苄基-N-(5-甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂环庚三烯-3-基)-4H-1,2,4-三唑-3-甲酰胺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1575050A1 (de) * 1966-01-12 1972-04-13 Misto Gen Equipment Co Ultraschall-Nebelerzeugungsgeraet
US4447235A (en) * 1981-05-07 1984-05-08 John M. Clarke Thoracentesis device
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
EP0303769A3 (de) * 1987-08-18 1989-10-25 Balzers Aktiengesellschaft Vorrichtung zur Übertragung von Drehbewegungen durch die Wand einer Vakuumkammer
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
JPH02124251A (ja) 1988-10-28 1990-05-11 Tanaka Kikinzoku Kogyo Kk 微細穴加工方法
US5123903A (en) * 1989-08-10 1992-06-23 Medical Products Development, Inc. Disposable aspiration sleeve for ultrasonic lipectomy
US5317932A (en) * 1992-02-28 1994-06-07 The Dow Chemical Company Sample probe
US5300046A (en) * 1992-03-30 1994-04-05 Symbiosis Corporation Thoracentesis sheath catheter assembly
US5674235A (en) * 1995-05-10 1997-10-07 Ultralase Technologies International Ultrasonic surgical cutting instrument
JPH1024491A (ja) 1996-07-11 1998-01-27 Seidensha Denshi Kogyo Kk 超音波加工装置
US6783662B2 (en) * 1999-03-18 2004-08-31 Exxonmobil Research And Engineering Company Cavitation enhanced liquid atomization
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AU1444301A (en) * 1999-10-29 2001-05-14 Merck & Co., Inc. Osmotic controlled release drug delivery device
US7708504B2 (en) * 2005-08-29 2010-05-04 Savannah River Nuclear Solutions, Llc Pneumatic conveyance apparatus and process

Also Published As

Publication number Publication date
EP1333813A2 (de) 2003-08-13
ES2323879T3 (es) 2009-07-27
US8765065B2 (en) 2014-07-01
WO2002038131A2 (en) 2002-05-16
EP1655024A1 (de) 2006-05-10
WO2002038131A3 (en) 2002-09-12
ES2256329T3 (es) 2006-07-16
EP1333813B1 (de) 2006-01-04
DE60116530D1 (de) 2006-03-30
US7923027B2 (en) 2011-04-12
US20110131754A1 (en) 2011-06-09
ATE428407T1 (de) 2009-05-15
GB0027471D0 (en) 2000-12-27
US20040062806A1 (en) 2004-04-01
EP1655024B1 (de) 2009-04-15
DE60116530T2 (de) 2006-08-10
JP4290981B2 (ja) 2009-07-08
AU2002218280A1 (en) 2002-05-21
DE60138428D1 (de) 2009-05-28
JP2004512903A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE314839T1 (de) Prozess zur herstellung einer oralen arzneiform
CA2433032A1 (en) Sustained release drug delivery devices with coated drug cores
DE60237294D1 (de) Pharmazeutische zusammensetzung auf fondantbasis
USD489821S1 (en) Core for an absorbent article
SE9102072D0 (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
ATE385783T1 (de) Verfahren zur herstellung einer geschmacksmaskierten oralen darreichungsform& x9;
ATE438423T1 (de) Expandierbare medizinische ballons und verfahren zu ihrer herstellung
ATE380518T1 (de) Einstückiges dentalimplantat und verfahren zu dessen herstellung
DE60224111D1 (de) Bausatz zur Herstellung einer Verabreichungsform zur Abgabe einer bioaktiven Substanz
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
NO20035655L (no) Fremgangsmate for fremstilling av tabletter
DE60007815D1 (de) Coregarn, und Verfahren und Vorrichtung zur dessen Herstellung
WO2002102182A3 (en) Tongue and mouth stud for dispensing a substance
DE60202351D1 (de) Neuer filmüberzug
DE60137386D1 (de) Phosphor-Dünnfilm, Verfahren zur Herstellung und EL-Folie
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
DE60105358D1 (de) Beschichtetes Fasermaterial sowie Beschichtungslösung zur dessen Herstellung
DK1413259T3 (da) Dental formdel, især kunstig tand
USD504508S1 (en) Dental injection needle for dispensing anesthetic substance
DE50114938D1 (de) Maskenerstellung zur Herstellung einer Druckform
DE60114668D1 (de) Prozess zur Herstellung des Anti-Migräne Wirkstoffs Eletriptan
DE50207427D1 (de) Vorrichtung zur Herstellung palettierfähiger Lagen
DE50102461D1 (de) Keramischer grünkörper mit einer platinhaltigen, photostrukturierbaren funktionsschicht und verfahren zu dessen herstellung
ATE322877T1 (de) Behälter zur herstellung einer medizinischen lösung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties